Genetics of SCID

Italian Journal of Pediatrics

Volumn 36, Issue 1, 2010, Pages

  Cossu, Fausto ^a  

^a Osp Regionale per le Microcitemie   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; BUSULFAN; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CD3 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 7 RECEPTOR ALPHA; JANUS KINASE 3; KHELLIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEGYLATED ADENOSINE DEAMINASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN KINASE C; PROTEIN KINASE ZAP 70; PROTEIN P56; PURINE NUCLEOSIDE PHOSPHORYLASE; RAG1 PROTEIN; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOSINE DEAMINASE DEFICIENCY; APOPTOSIS; ARTEMIS DEFECT; DIGEORGE SYNDROME; DISEASE CLASSIFICATION; DRUG FATALITY; ENGRAFTMENT; GENE INSERTION; GENE MUTATION; GENE THERAPY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITARY FOLATE MALABSORPTION; HOYERAAL HREIDARSSON SYNDROME; HUMAN; NONHUMAN; OMENN SYNDROME; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY; RETICULAR DYSGENESIS; RETINA MALFORMATION; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; GENETICS; NEWBORN; NEWBORN SCREENING; PATHOLOGY; T LYMPHOCYTE;

GENE THERAPY; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES;

EID: 79952202248     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-36-76     Document Type: Review

References (124)

1. Le basi genetiche delle SCID. Cossu F, Prospettive in Pediatria 2009 156 228 238
2. Ochs HD, Smith CIE, Puck J, Primary Immunodeficiency Diseases: A Molecular and Genetic Approach New York: Oxford University Press 2007
3. Stiehm ER, Ochs HD, Winkelstein JA, Immunologic disorders in infants & children Philadelphia, Pennsylvania: Elsevier Saunders 2004
4. Implementing routine testing for severe combined immunodeficiency within Wisconsin's newborn screening program. Baker MW, Laessig RH, Katcher ML, Routes JM, Grossman WJ, Verbsky J, Kurtycz DF, Brokopp CD, Public Health Rep 2010 125 Suppl 2 88 95 http://www.publichealthreports.org/archives/issueopen.cfm? articleID=2428 20518449
5. Identification of an infant with severe combined immunodeficiency by newborn screening. Hale JE, Bonilla FA, Pai SY, Gerstel-Thompson JL, Notarangelo LD, Eaton RB, Comeau AM, J Allergy Clin Immunol 2010 126 1073 1074 10.1016/j.jaci.2010.08.043 20933257
6. SCID added to national newborn screening standards. Am J Med Genet A 2010 152A 8 x 10.1002/ajmg.a.33645 20662017
7. Severe combined immunodeficiency: a pediatric emergency. Rosen FS, J Pediatr 1997 130 345 346 9063405 (Pubitemid 27492674)
8. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, Revell PA, Hanson IC, Paul ME, Rosenblatt HM, Abramson SL, N Engl J Med 2010 362 314 319 10.1056/NEJMoa0904485 20107217
9. Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine. Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep 2010 59 687 688 20535093
10. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Mold JE, Michalsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, Lee TH, Nixon DF, McCune JM, Science 2008 322 1562 1565 10.1126/science.1164511 19056990
11. In utero transplantation: baby steps towards an effective therapy. Muench MO, Bone Marrow Transplant 2005 35 537 547 10.1038/sj.bmt.1704811 15665844 (Pubitemid 40450451)
12. The functional plasticity of T cell subsets. Bluestone JA, Mackay CR, O'Shea JJ, Stockinger B, Nat Rev Immunol 2009 9 811 816 10.1038/nri2654 19809471
13. Multi-tasking of helper T cells. Wan YY, Immunology 2010 130 166 171 10.1111/j.1365-2567.2010.03289.x 20557575
14. Why newborn screening for severe combined immunodeficiency is essential: a case report. Adeli MM, Buckley RH, Pediatrics 2010 126 465 e469 10.1542/peds.2009-3659 20603253
15. Immunodeficiency due to mutations in ORAI1 and STIM1. Feske S, Picard C, Fischer A, Clin Immunol 2010 135 169 182 10.1016/j.clim.2010.01.011 20189884
16. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Turul T, Tezcan I, Artac H, de Bruin-Versteeg S, Barendregt BH, Reisli I, Sanal O, van Dongen JJ, van der Burg M, Eur J Pediatr 2009 168 87 93 10.1007/s00431-008-0718-x 18509675
17. - SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I, Br J Haematol 2002 119 765 768 10.1046/j.1365-2141. 2002.03822.x 12437656 (Pubitemid 35366220)
18. Cutaneous manifestations of maternal engraftment in patients with severe combined immunodeficiency: a clinicopathologic study. Denianke KS, Frieden IJ, Cowan MJ, Williams ML, McCalmont TH, Bone Marrow Transplant 2001 28 227 233 10.1038/sj.bmt.1703128 11535989 (Pubitemid 32780874)
19. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R, Chen DF, Reinsmoen NL, Buckley RH, J Allergy Clin Immunol 2007 120 423 428 10.1016/j.jaci.2007.02.047 17481714 (Pubitemid 47102368)
20. Monoclonal IgA gammopathy due to maternal B cells in an infant with severe combined immunodeficiency (SCID) prior to hematopoietic stem cell transplantation. Kobrynski LJ, Abramowsky C, J Pediatr Hematol Oncol 2006 28 53 56 16394896 (Pubitemid 43361622)
21. Long-term survival in severe combined immune deficiency: the role of persistent maternal engraftment. Tezcan I, Ersoy F, Sanal O, Turul T, Uckan D, Balci S, Hicsonmez G, Prieur M, Caillat-Zucmann S, Le Deist F, De Saint Basile G, J Pediatr 2005 146 137 140 10.1016/j.jpeds.2004.09.010 15644840 (Pubitemid 40091746)
22. Omenn syndrome: a disorder of Rag1 and Rag2 genes. Villa A, Santagata S, Bozzi F, Imberti L, Notarangelo LD, J Clin Immunol 1999 19 87 97 10.1023/A:1020550432126 10226883 (Pubitemid 29187924)
23. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. Villa A, Notarangelo LD, Roifman CM, J Allergy Clin Immunol 2008 122 1082 1086 10.1016/j.jaci.2008.09.037 18992930
24. Adenosine deaminase deficiency can present with features of Omenn syndrome. Roifman CM, Zhang J, Atkinson A, Grunebaum E, Mandel K, J Allergy Clin Immunol 2008 121 1056 1058 10.1016/j.jaci.2007.12.1148 18243287
25. Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency. Gruber TA, Shah AJ, Hernandez M, Crooks GM, Abdel-Azim H, Gupta S, McKnight S, White D, Kapoor N, Kohn DB, Pediatr Transplant 2009 13 244 250 10.1111/j.1399-3046.2008.00970.x 18822103
26. Omenn syndrome in an infant with IL7RA gene mutation. Giliani S, Bonfim C, de Saint Basile G, Lanzi G, Brousse N, Koliski A, Malvezzi M, Fischer A, Notarangelo LD, Le Deist F, J Pediatr 2006 148 272 274 10.1016/j.jpeds.2005.10. 004 16492442 (Pubitemid 43286773)
27. Omenn syndrome due to ARTEMIS mutations. Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, Schwarz K, Pannicke U, Blood 2005 105 4179 4186 10.1182/blood-2004-12-4861 15731174 (Pubitemid 40720760)
28. Omenn syndrome is associated with mutations in DNA ligase IV. Grunebaum E, Bates A, Roifman CM, J Allergy Clin Immunol 2008 122 1219 1220 10.1016/j.jaci.2008.08.031 18845326
29. Congenital Alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency in two sibs. Pignata C, Fiore M, Guzzetta V, Castaldo A, Sebastio G, Porta F, Guarino A, Am J Med Genet 1996 65 167 170 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O 8911612
30. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, Sempowski GD, Rhein ME, Szabolcs P, Hale LP, Buckley RH, Coyne KE, Rice HE, Mahaffey SM, Skinner MA, J Allergy Clin Immunol 2004 113 734 741 10.1016/j.jaci.2004.01.766 15100681 (Pubitemid 38530431)
31. + severe combined immune deficiency and may cause Omenn-like syndrome. Gennery AR, Slatter MA, Rice J, Hoefsloot LH, Barge D, McLean-Tooke A, Montgomery T, Goodship JA, Burt AD, Flood TJ, Abinun M, Cant AJ, Johnson D, Clin Exp Immunol 2008 153 75 80 10.1111/j.1365-2249.2008. 03681.x 18505430 (Pubitemid 351809347)
32. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. Roifman CM, Gu Y, Cohen A, J Allergy Clin Immunol 2006 117 897 903 10.1016/j.jaci.2006.01.003 16630949
33. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation. Liston A, Enders A, Siggs OM, Nat Rev Immunol 2008 8 545 558 10.1038/nri2336 18551129 (Pubitemid 351913676)
34. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Poliani PL, Facchetti F, Ravanini M, Gennery AR, Villa A, Roifman CM, Notarangelo LD, Blood 2009 114 105 108 10.1182/blood-2009-03-211029 19414857
35. Defect of regulatory T cells in patients with Omenn syndrome. Cassani B, Poliani PL, Moratto D, Sobacchi C, Marrella V, Imperatori L, Vairo D, Plebani A, Giliani S, Vezzoni P, Facchetti F, Porta F, Notarangelo LD, Villa A, Badolato R, J Allergy Clin Immunol 2010 125 209 216 10.1016/j.jaci.2009.10.023 20109747
36. More than just SCID-the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Niehues T, Perez-Becker R, Schuetz C, Clin Immunol 2010 135 183 192 10.1016/j.clim.2010.01.013 20172764
37. Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype. Notarangelo LD, Roifman CM, Giliani S, Curr Opin Allergy Clin Immunol 2008 8 534 539 10.1097/ACI.0b013e328310fe7d 18978468
38. Variable phenotypic expression of mutations in genes of the immune system. Buckley RH, J Clin Invest 2005 115 2974 2976 10.1172/JCI26956 16276411 (Pubitemid 41567562)
39. Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency. Umetsu DT, Schlossman CM, Ochs HD, Hershfield MS, J Allergy Clin Immunol 1994 93 543 550 10.1016/0091-6749(94)90365-4 8120281 (Pubitemid 24081797)
40. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings. Pasic S, Djuricic S, Ristic G, Slavkovic B, Acta Paediatr 2009 98 1062 1064 10.1111/j.1651-2227.2009.01250.x 19243569
41. Somatic mosaicism in primary immune deficiencies. Wada T, Candotti F, Curr Opin Allergy Clin Immunol 2008 8 510 514 10.1097/ACI.0b013e328314b651 18978464
42. A special report: four-year study of a boy with combined immune deficiency maintained in strict reverse isolation from birth. Williamson AP, Montgomery JR, South MA, Wilson R, (Eds), Pediatr Res 1977 11 63 89 10.1203/00006450-197701000-00001 401538 (Pubitemid 8009624)
43. Immunoregulation in an isolated 12-year-old boy with congenital severe combined immunodeficiency. Paschall VL, Brown LA, Lawrence EC, Karol RA, Lotzova E, Brown BS, Shearer WT, Pediatr Res 1984 18 723 728 10.1203/00006450- 198408000-00009 6332299 (Pubitemid 14052231)
44. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet FC, Cleary ML, Warnke R, Sklar J, N Engl J Med 1985 312 1151 1159 10.1056/NEJM198505023121804 2984567 (Pubitemid 15008031)
45. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ, Cell 1993 73 147 157 10.1016/0092-8674(93)90167-O 8462096 (Pubitemid 23115456)
46. The "bubble boy" paradox: an answer that led to a question. Berg LJ, J Immunol 2008 181 5815 5816 18941168
47. cfamily cytokines. Rochman Y, Spolski R, Leonard WJ, Nat Rev Immunol 2009 9 480 490 10.1038/nri2580 19543225
48. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common c cytokine receptor subunit or JAK-3 deficiency. Laffort C, Le Deist F, Favre M, Caillat-Zucman S, Radford-Weiss I, Debré M, Fraitag S, Blanche S, Cavazzana-Calvo M, de Saint Basile G, de Villartay JP, Giliani S, Orth G, Casanova JL, Bodemer C, Fischer A, Lancet 2004 363 2051 2054 10.1016/S0140-6736(04)16457-X 15207958 (Pubitemid 38781108)
49. Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options. De Ravin SS, Malech HL, Immunol Res 2009 43 223 242 10.1007/s12026-008-8073-6 18979075
50. Efficacy of gene therapy for X-linked severe combined immunodeficiency. Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M, N Engl J Med 2010 363 355 364 10.1056/NEJMoa1000164 20660403
51. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs. Pesu M, Candotti F, Husa M, Hofmann SR, Notarangelo LD, O'Shea JJ, Immunol Rev 2005 203 127 142 10.1111/j.0105-2896.2005.00220.x 15661026 (Pubitemid 40179698)
52. Janus kinases in immune cell signaling. Ghoreschi K, Laurence A, O'Shea JJ, Immunol Rev 2009 228 273 287 10.1111/j.1600-065X.2008.00754.x 19290934
53. + severe combined immunodeficiency disease. Puel A, Leonard WJ, Curr Opin Immunol 2000 12 468 473 10.1016/S0952-7915(00)00122-9 10899029 (Pubitemid 30410355)
54. Interleukin-7 receptor (IL-7R) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Giliani S, Mori L, de Saint Basile G, Le Deist F, Rodriguez-Perez C, Forino C, Mazzolari E, Dupuis S, Elhasid R, Kessel A, Galambrun C, Gil J, Fischer A, Etzioni A, Notarangelo LD, Immunol Rev 2005 203 110 126 10.1111/j.0105-2896.2005.00234.x 15661025 (Pubitemid 40179697)
55. Naive T cell homeostasis: from awareness of space to a sense of place. Takada K, Jameson SC, Nat Rev Immunol 2010 9 12 823 832 10.1038/nri2657 19935802
56. Two-tiered universal newborn screening strategy for severe combined immunodeficiency. McGhee SA, Stiehm ER, Cowan M, Krogstad P, McCabe ER, Mol Genet Metab 2005 86 427 430 10.1016/j.ymgme.2005.09.005 16260163 (Pubitemid 41796483)
57. Receptor editing in lymphocyte development and central tolerance. Nemazee D, Nat Rev Immunol 2006 6 728 740 10.1038/nri1939 16998507 (Pubitemid 44453459)
58. T cell activation. Smith-Garvin JE, Koretzky GA, Jordan MS, Annu Rev Immunol 2009 27 591 619 10.1146/annurev.immunol.021908.132706 19132916
59. Primary B cell immunodeficiencies: comparisons and contrasts. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, Coustan-Smith E, Howard V, Campana D, Annu Rev Immunol 2009 27 199 227 10.1146/annurev.immunol.021908. 132649 19302039
60. V(D)J recombination deficiencies. de Villartay JP, Adv Exp Med Biol 2009 650 46 58 full-text 19731800
61. Structural biology of DNA repair: spatial organisation of the multicomponent complexes of nonhomologous end joining. Ochi T, Sibanda BL, Wu Q, Chirgadze DY, Bolanos-Garcia VM, Blundell TL, J Nucleic Acids 2010 2010 ii: 621695 10.4061/2010/621695 20862368
62. Radiosensitive severe combined immunodeficiency disease. Dvorak CC, Cowan MJ, Immunol Allergy Clin North Am 2010 30 125 142 10.1016/j.iac.2009.10.004 20113890
63. RAG-dependent primary immunodeficiencies. Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A, Hum Mutat 2006 27 1174 1184 10.1002/humu.20408 16960852 (Pubitemid 44749719)
64. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. Li L, Moshous D, Zhou Y, Wang J, Xie G, Salido E, Hu D, de Villartay JP, Cowan MJ, J Immunol 2002 168 6323 6329 12055248 (Pubitemid 34620054)
65. Ligase IV syndrome. Chistiakov DA, Voronova NV, Chistiakov AP, Eur J Med Genet 2009 52 373 378 10.1016/j.ejmg.2009.05.009 19467349
66. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Buck D, Malivert L, de Chasseval R, Barraud A, Fondanèche MC, Sanal O, Plebani A, Stéphan JL, Hufnagel M, le Deist F, Fischer A, Durandy A, de Villartay JP, Revy P, Cell 2006 124 287 299 10.1016/j.cell.2005.12.030 16439204 (Pubitemid 43121978)
67. DNA-PKcs deficiency in human: long predicted, finally found. van der Burg M, van Dongen JJ, van Gent DC, Curr Opin Allergy Clin Immunol 2009 9 503 509 10.1097/ACI.0b013e3283327e41 19823081
68. Differential biological role of CD3 chains revealed by human immunodeficiencies. Recio MJ, Moreno-Pelayo MA, Kiliç SS, Guardo AC, Sanal O, Allende LM, Pérez-Flores V, Mencía A, Modamio-Høybjør S, Seoane E, Regueiro JR, J Immunol 2007 178 2556 2564 17277165 (Pubitemid 46233458)
69. + severe combined immunodeficiency caused by complete deficiency of the CD3 subunit of the T-cell antigen receptor complex. Roberts JL, Lauritsen JP, Cooney M, Parrott RE, Sajaroff EO, Win CM, Keller MD, Carpenter JH, Carabana J, Krangel MS, Sarzotti M, Zhong XP, Wiest DL, Buckley RH, Blood 2007 109 3198 3206 10.1182/blood-2006-08-043166 17170122 (Pubitemid 46572504)
70. A deletion in the gene encoding the CD45 antigen in a patient with SCID. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC, J Immunol 2001 166 1308 1313 11145714 (Pubitemid 32060292)
71. Altered CD45 expression and disease. Tchilian EZ, Beverley PC, Trends Immunol 2006 27 146 153 10.1016/j.it.2006.01.001 16423560
72. The structure, regulation, and function of ZAP-70. Au-Yeung BB, Deindl S, Hsu LY, Palacios EH, Levin SE, Kuriyan J, Weiss A, Immunol Rev 2009 228 41 57 10.1111/j.1600-065X.2008.00753.x 19290920
73. Defective expression of p56lck in an infant with severe combined immunodeficiency. Goldman FD, Ballas ZK, Schutte BC, Kemp J, Hollenback C, Noraz N, Taylor N, J Clin Invest 1998 102 421 429 10.1172/JCI3205 9664084 (Pubitemid 28335202)
74. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Hubert P, Bergeron F, Ferreira V, Seligmann M, Oksenhendler E, Debre P, Autran B, Int Immunol 2000 12 449 457 10.1093/intimm/12.4.449 10744646 (Pubitemid 30199350)
75. Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Lagresle-Peyrou C, Six EM, Picard C, Rieux-Laucat F, Michel V, Ditadi A, Demerens-de Chappedelaine C, Morillon E, Valensi F, Simon-Stoos KL, Mullikin JC, Noroski LM, Besse C, Wulffraat NM, Ferster A, Abecasis MM, Calvo F, Petit C, Candotti F, Abel L, Fischer A, Cavazzana-Calvo M, Nat Genet 2009 41 106 111 10.1038/ng.278 19043416
76. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Pannicke U, Hönig M, Hess I, Friesen C, Holzmann K, Rump EM, Barth TF, Rojewski MT, Schulz A, Boehm T, Friedrich W, Schwarz K, Nat Genet 2009 41 101 105 10.1038/ng.265 19043417
77. Adenylate kinase and AMP signaling networks: Metabolic monitoring, signal communication and body energy sensing. Dzeja P, Terzic A, Int J Mol Sci 2009 10 1729 1772 10.3390/ijms10041729 19468337
78. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schäffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K, Nat Genet 2007 39 86 92 10.1038/ng1940 17187068 (Pubitemid 46026506)
79. Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients. Cassani B, Mirolo M, Cattaneo F, Benninghoff U, Hershfield M, Carlucci F, Tabucchi A, Bordignon C, Roncarolo MG, Aiuti A, Blood 2008 111 4209 4219 10.1182/blood-2007-05-092429 18218852
80. New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. Sauer AV, Aiuti A, Curr Opin Allergy Clin Immunol 2009 9 496 502 10.1097/ACI.0b013e3283327da5 19779332
81. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Sauer AV, Mrak E, Hernandez RJ, Zacchi E, Cavani F, Casiraghi M, Grunebaum E, Roifman CM, Cervi MC, Ambrosi A, Carlucci F, Roncarolo MG, Villa A, Rubinacci A, Aiuti A, Blood 2009 114 3216 3226 10.1182/blood-2009-03-209221 19633200
82. Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Hönig M, Albert MH, Schulz A, Sparber-Sauer M, Schütz C, Belohradsky B, Güngör T, Rojewski MT, Bode H, Pannicke U, Lippold D, Schwarz K, Debatin KM, Hershfield MS, Friedrich W, Blood 2007 109 3595 3602 10.1182/blood-2006-07-034678 17185467 (Pubitemid 46572555)
83. Inherited disorders in the conversion of methionine to homocysteine. Bari I, J Inherit Metab Dis 2009 32 459 471 10.1007/s10545-009-1146-4 19585268
84. How I treat ADA deficiency. Gaspar HB, Aiuti A, Porta F, Candotti F, Hershfield MS, Notarangelo LD, Blood 2009 114 3524 3532 10.1182/blood-2009-06- 189209 19638621
85. Bone marrow transplantation and alternatives for adenosine deaminase deficiency. Gaspar HB, Immunol Allergy Clin North Am 2010 30 221 236 10.1016/j.iac.2010.01.002 20493398
86. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG, N Engl J Med 2009 360 447 458 10.1056/NEJMoa0805817 19179314
87. Purine nucleoside phosphorylase deficiency with fatal course in two sisters. Aytekin C, Dogu F, Tanir G, Guloglu D, Santisteban I, Hershfield MS, Ikinciogullari A, Eur J Pediatr 2010 169 311 314 10.1007/s00431-009-1029-6 19657670
88. Thymus organogenesis. Rodewald HR, Annu Rev Immunol 2008 26 355 388 10.1146/annurev.immunol.26.021607.090408 18304000 (Pubitemid 351600380)
89. Thymus microenvironment in human primary immunodeficiency diseases. Poliani PL, Vermi W, Facchetti F, Curr Opin Allergy Clin Immunol 2009 9 489 95 10.1097/ACI.0b013e3283327e5c 19841578
90. Exposing the human nude phenotype. Frank J, Pignata C, Panteleyev AA, Prowse DM, Baden H, Weiner L, Gaetaniello L, Ahmad W, Pozzi N, Cserhalmi-Friedman PB, Aita VM, Uyttendaele H, Gordon D, Ott J, Brissette JL, Christiano AM, Nature 1999 398 473 474 10.1038/18997 10206641 (Pubitemid 29177477)
91. Ancestral founder mutation of the nude (FOXN1) gene in congenital severe combined immunodeficiency associated with alopecia in southern Italy population. Adriani M, Martinez-Mir A, Fusco F, Busiello R, Frank J, Telese S, Matrecano E, Ursini MV, Christiano AM, Pignata C, Ann Hum Genet 2004 68 (Pt 3):265 268 10.1046/j.1529-8817.2004.00091.x (Pubitemid 39162739)
92. FOXN1 homozygous mutation associated with anencephaly and severe neural tube defect in human athymic Nude/SCID fetus. Amorosi S, D'Armiento M, Calcagno G, Russo I, Adriani M, Christiano AM, Weiner L, Brissette JL, Pignata C, Clin Genet 2008 73 380 384 10.1111/j.1399-0004.2008.00977.x 18339010 (Pubitemid 351386999)
93. Thymus transplantation in complete DiGeorge anomaly. Markert ML, Devlin BH, Chinn IK, McCarthy EA, Immunol Res 2009 44 61 70 10.1007/s12026-008-8082-5 19066739
94. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Kobrynski LJ, Sullivan KE, Lancet 2007 370 1443 1452 10.1016/S0140-6736(07)61601-8 17950858 (Pubitemid 47576169)
95. CHARGE syndrome. Blake KD, Prasad C, Orphanet J Rare Dis 2006 1 34 10.1186/1750-1172-1-34 16959034
96. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Jyonouchi S, McDonald-McGinn DM, Bale S, Zackai EH, Sullivan KE, Pediatrics 2009 123 871 877 10.1542/peds.2008-3400 19403480
97. Teratogenicity associated with pre-existing and gestational diabetes. Allen VM, Armson BA, Wilson RD, Allen VM, Blight C, Gagnon A, Johnson JA, Langlois S, Summers A, Wyatt P, Farine D, Armson BA, Crane J, Delisle MF, Keenan-Lindsay L, Morin V, Schneider CE, Van Aerde J, Society of Obstetricians and Gynecologists of Canada, J Obstet Gynaecol Can 2007 29 927 944 10.1097/GRF.0b013e318159c4fc 17977497 (Pubitemid 350059289)
98. Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. Rice HE, Skinner MA, Mahaffey SM, Oldham KT, Ing RJ, Hale LP, Markert ML, J Pediatr Surg 2004 39 1607 1615 10.1016/j.jpedsurg.2004. 07.020 15547821 (Pubitemid 39487986)
99. Thymus transplantation. Markert ML, Devlin BH, McCarthy EA, Clin Immunol 2010 135 236 246 10.1016/j.clim.2010.02.007 20236866
100. Immunologic reconstitution in 22q deletion (DiGeorge) syndrome. McGhee SA, Lloret MG, Stiehm ER, Immunol Res 2009 45 37 45 10.1007/s12026-009-8108-7 19238335
101. Calcium signalling in lymphocyte activation and disease. Feske S, Nat Rev Immunol 2007 7 690 702 10.1038/nri2152 17703229 (Pubitemid 47327393)
102. The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency. Shiow LR, Roadcap DW, Paris K, Watson SR, Grigorova IL, Lebet T, An J, Xu Y, Jenne CN, Föger N, Sorensen RU, Goodnow CC, Bear JE, Puck JM, Cyster JG, Nat Immunol 2008 9 1307 1315 10.1038/ni.1662 18836449
103. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Shiow LR, Paris K, Akana MC, Cyster JG, Sorensen RU, Puck JM, Clin Immunol 2009 131 24 30 10.1016/j.clim.2008.11.002 19097825
104. The actin cytoskeleton in T cell activation. Burkhardt JK, Carrizosa E, Shaffer MH, Annu Rev Immunol 2008 26 233 259 10.1146/annurev.immunol.26.021607. 090347 18304005 (Pubitemid 351600376)
105. Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency. Picard C, Fischer A, Immunol Allergy Clin North Am 2010 30 173 178 10.1016/j.iac.2010.01.001 20493394
106. Advances in the understanding of dyskeratosis congenita. Walne AJ, Dokal I, Br J Haematol 2009 145 164 172 10.1111/j.1365-2141.2009.07598.x 19208095
107. Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Marrone A, Walne A, Tamary H, Masunari Y, Kirwan M, Beswick R, Vulliamy T, Dokal I, Blood 2007 110 4198 4205 10.1182/blood-2006-12-062851 17785587 (Pubitemid 351377783)
108. Telomeres: protecting chromosomes against genome instability. O'Sullivan RJ, Karlseder J, Nat Rev Mol Cell Biol 2010 11 171 181 10.1038/nrg2761 20125188
109. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I, Blood 2008 112 3594 3600 10.1182/blood-2008-05-153445 18669893
110. Function of Apollo (SNM1B) at telomere highlighted by a splice variant identified in a patient with Hoyeraal-Hreidarsson syndrome. Touzot F, Callebaut I, Soulier J, Gaillard L, Azerrad C, Durandy A, Fischer A, de Villartay JP, Revy P, Proc Natl Acad Sci USA 2010 107 10097 10102 10.1073/pnas.0914918107 20479256
111. A syndrome involving intrauterine growth retardation, microcephaly, cerebellar hypoplasia, B lymphocyte deficiency, and progressive pancytopenia. Revy P, Busslinger M, Tashiro K, Arenzana F, Pillet P, Fischer A, Durandy A, Pediatrics 2000 105 39 10.1542/peds.105.3.e39 10699141
112. Reversible severe combined immunodeficiency phenotype secondary to a mutation of the proton-coupled folate transporter. Borzutzky A, Crompton B, Bergmann AK, Giliani S, Baxi S, Martin M, Neufeld EJ, Notarangelo LD, Clin Immunol 2009 133 287 294 10.1016/j.clim.2009.08.006 19740703
113. Single-center analysis of long-term outcome after hematopoietic cell transplantation in children with congenital severe T cell immunodeficiency. Mazzolari E, de Martiis D, Forino C, Lanfranchi A, Giliani S, Marzollo R, Air P, Imberti L, Porta F, Notarangelo LD, Immunol Res 2009 44 4 17 10.1007/s12026-008-8022-4 18592143
114. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, Mahlaoui N, Debré M, Casanova JL, Dal Cortivo L, Madec Y, Hacein-Bey-Abina S, de Saint Basile G, de Villartay JP, Blanche S, Cavazzana-Calvo M, Fischer A, Blood 2009 113 4114 4124 10.1182/blood-2008-09-177923 19168787
115. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. Railey MD, Lokhnygina Y, Buckley RH, J Pediatr 2009 155 834 840 10.1016/j.jpeds.2009.07.049 19818451
116. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, Amrolia PJ, Gaspar HB, Davies EG, Friedrich W, Hoenig M, Notarangelo LD, Mazzolari E, Porta F, Bredius RG, Lankester AC, Wulffraat NM, Seger R, Güngör T, Fasth A, Sedlacek P, Neven B, Blanche S, Fischer A, Cavazzana-Calvo M, Landais P, Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency, J Allergy Clin Immunol 2010 126 602 610 10.1016/j.jaci.2010.06.015 20673987
117. Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency. Cuvelier GD, Schultz KR, Davis J, Hirschfeld AF, Junker AK, Tan R, Turvey SE, Clin Immunol 2009 131 179 188 10.1016/j.clim.2009. 01.003 19217351
118. Reduced intensity transplantation for primary immunodeficiency disorders. Veys P, Immunol Allergy Clin North Am 2010 30 103 124 10.1016/j.iac.2009.11.003 20113889
119. Progress and prospects: gene therapy for inherited immunodeficiencies. Qasim W, Gaspar HB, Thrasher AJ, Gene Ther 2009 16 1285 1291 10.1038/gt.2009.127 19776764
120. 20 years of gene therapy for SCID. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Nat Immunol 2010 11 457 460 10.1038/ni0610-457 20485269
121. Occurrence of leukaemia following gene therapy of X-linked SCID. Kohn DB, Sadelain M, Glorioso JC, Nat Rev Cancer 2003 3 477 488 10.1038/nrc1122 12835668 (Pubitemid 37328836)
122. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, Gilmour KC, Adams S, Thornhill SI, Parsley KL, Staal FJ, Gale RE, Linch DC, Bayford J, Brown L, Quaye M, Kinnon C, Ancliff P, Webb DK, Schmidt M, von Kalle C, Gaspar HB, Thrasher AJ, J Clin Invest 2008 118 3143 3150 10.1172/JCI35798 18688286
123. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Zhou S, Mody D, DeRavin SS, Hauer J, Lu T, Ma Z, Hacein-Bey Abina S, Gray JT, Greene MR, Cavazzana-Calvo M, Malech HL, Sorrentino BP, Blood 2010 116 900 908 10.1182/blood-2009-10-250209 20457870
124. Transfusion independence and HMGA2 activation after gene therapy of human -thalassaemia. Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F, Down J, Denaro M, Brady T, Westerman K, Cavallesco R, Gillet-Legrand B, Caccavelli L, Sgarra R, Maouche-Chrétien L, Bernaudin F, Girot R, Dorazio R, Mulder GJ, Polack A, Bank A, Soulier J, Larghero J, Kabbara N, Dalle B, Gourmel B, Socie G, Chrétien S, Cartier N, Aubourg P, Fischer A, Cornetta K, Galacteros F, Beuzard Y, Gluckman E, Bushman F, Hacein-Bey-Abina S, Leboulch P, Nature 2010 467 318 322 10.1038/nature09328 20844535